Distributions for selected characteristics of the prostate cancer patient cohort by recurrence status
| Recurrence (n = 104) | No recurrence (n = 303) | |
|---|---|---|
| Characteristic | n (%) | n (%) |
| Age at diagnosis, y | ||
| 35–54 | 33 (31.7) | 92 (30.4) |
| 55–59 | 18 (17.3) | 77 (25.4) |
| 60–64 | 34 (32.7) | 86 (28.4) |
| 65–69 | 12 (11.5) | 28 (9.2) |
| 70–74 | 7 (6.7) | 20 (6.6) |
| Mean age (± SE) | 58.5 (7.18) | 58.2 (7.10) |
| PSA at diagnosis, ng/mL | ||
| 0–3.9 | 13 (12.5) | 54 (17.8) |
| 4–9.9 | 45 (43.3) | 189 (62.4) |
| 10–19.9 | 24 (23.1) | 28 (9.2) |
| 20 + | 15 (14.4) | 14 (4.6) |
| Missing | 7 (6.7) | 18 (5.9) |
| Pathologic stage | ||
| Local | 47 (45.2) | 235 (77.6) |
| Regional | 57 (54.8) | 68 (22.4) |
| Gleason score | ||
| 2–5 | 8 (7.7) | 37 (12.2) |
| 6 | 16 (15.4) | 136 (44.9) |
| 7 (3 + 4) | 45 (43.3) | 101 (33.3) |
| 7 (4 + 3) | 17 (16.4) | 16 (5.3) |
| 8–10 | 18 (17.3) | 13 (4.3) |